The Dublin-based biotech company r
esearches and develops proteins and reagents that are provided to pharmaceutical companies that in turn develop diagnostic tests for viruses. CEO of Aalto Bio, Philip Noone who has been working in the virus diagnostics space for twenty-five years, says his company has been working on the clinical trials with a couple of companies who are developing vaccines. They include the American pharma giant, Moderna., about the pace at which the vaccine development is happening:Moderna have done their phase two clinical trials. You do three phases of clinical trials before you bring the product to market.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Full interview with Philip Noone, CEO of aalto_bio here: sp 🤝 with EOYIreland